Colorectal Neoplasms: all 5,738 studies

Page 17 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.

• Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native PeopleCompletedNCT04336397Not applicableResults posted
• A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal CancerCompletedNCT04322539Phase 3Results posted
• A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)CompletedNCT04317599Results posted
• TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersCompletedNCT04306900Phase 1Results posted
• Test Up Now Education ProgramCompletedNCT04304001Not applicableResults posted
• Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.CompletedNCT04299048Phase 1Results posted
• Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic CholangiocarcinomaTerminatedNCT04276090Not applicableResults posted
• Enhancing Cancer Prevention and Control Pathways-Native Health InitiativeCompletedNCT04259762Not applicableResults posted
• Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination TreatmentCompletedNCT04256707Phase 1/2Results posted
• PRevention Using EPA Against coloREctal CancerCompletedNCT04216251Phase 1/2Results posted
• Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic CancerCompletedNCT04208958Phase 1/2Results posted
• Ancillary Study of Methylation Biomarkers in a Randomized Controlled Trial of a Personalized Prevention of Colorectal CancerCompletedNCT04196803Not applicableResults posted
• Virtual Human Delivered Nutrition Module for Colorectal Cancer PreventionCompletedNCT04192071Not applicableResults posted
• TMZ + Olaparib for MGMT Hypermethylated Colorectal CancerCompletedNCT04166435Phase 2Results posted
• VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)TerminatedNCT04166383Phase 2Results posted
• Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)CompletedNCT04126733Phase 2Results posted
• Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerActive, not recruitingNCT04117945Phase 2Results posted
• TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO StudyCompletedNCT04109924Phase 2Results posted
• Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR AlterationsActive, not recruitingNCT04096417Phase 2Results posted
• Virtual Reality for Improving Pain and Distress in Patients With Advanced Stage Colorectal CancerCompletedNCT04069702Not applicableResults posted
• Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal CancerTerminatedNCT04034355Phase 3Results posted
• A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)Active, not recruitingNCT04008030Phase 3Results posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerActive, not recruitingNCT03992456Phase 2Results posted
• Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCCompletedNCT03989115Phase 1/2Results posted
• Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal CancerActive, not recruitingNCT03983993Phase 2Results posted
• Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal CancerCompletedNCT03981614Phase 2Results posted
• A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal CancerCompletedNCT03981146Phase 2Results posted
• Promoting Informed Decisions About Cancer Screening in Older AdultsCompletedNCT03959696Not applicableResults posted
• A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)TerminatedNCT03948763Phase 1Results posted
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsCompletedNCT03935282Not applicableResults posted
• Screen to Save: A Colorectal Cancer Educational InterventionCompletedNCT03907579Not applicableResults posted
• Polyp Measurement DeviceTerminatedNCT03856255Not applicableResults posted
• Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic MetastasesTerminatedNCT03844750Phase 2Results posted
• Effectiveness and Implementation of mPATH-CRCCompletedNCT03843957Not applicableResults posted
• Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer PatientsActive, not recruitingNCT03829462Phase 3Results posted
• Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS MutationCompletedNCT03829410Phase 1/2Results posted
• Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal CancerCompletedNCT03828799Phase 1/2Results posted
• Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal CancerCompletedNCT03800602Phase 2Results posted
• Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)CompletedNCT03797326Phase 2Results posted
• BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRCTerminatedNCT03791398Phase 1/2Results posted
• Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic CancersTerminatedNCT03785210Phase 2Results posted
• Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer SurvivorsTerminatedNCT03781778Phase 2Results posted
• A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal CancerCompletedNCT03750786Phase 3Results posted
• DC Vaccine in Colorectal CancerTerminatedNCT03730948Phase 1Results posted
• An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act NowCompletedNCT03728348Results posted
• A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaCompletedNCT03693807Phase 2Results posted
• Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerCompletedNCT03693170Phase 2Results posted
• A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal PolyposisCompletedNCT03688555Phase 2Results posted
• PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
• Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal CancerActive, not recruitingNCT03657641Phase 1/2Results posted
• Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)TerminatedNCT03654729Phase 3Results posted
• Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal CancerCompletedNCT03642067Phase 2Results posted
• Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)CompletedNCT03631407Phase 2Results posted
• EXERCISING TOGETHER for Couples Coping With CancerCompletedNCT03630354Not applicableResults posted
• Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal AdenocarcinomaTerminatedNCT03610490Phase 2Results posted
• Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy CompletionCompletedNCT03598166Not applicableResults posted
• Internet-Based Motivational Interviewing for ColonoscopyCompletedNCT03595904Not applicableResults posted
• Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal CancerTerminatedNCT03592641Phase 2Results posted
• QUILT 3.071: NANT Colorectal Cancer (CRC) VaccineTerminatedNCT03563157Phase 1/2Results posted
• A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)TerminatedNCT03555149Phase 1/2Results posted
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRCTerminatedNCT03549338Phase 2Results posted
• A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRCTerminatedNCT03547999Phase 2Results posted
• Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal CancerCompletedNCT03542877Phase 2Results posted
• MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal CancerCompletedNCT03531632Phase 1/2Results posted
• Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer SurvivorsCompletedNCT03520283Not applicableResults posted
• Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation StatusCompletedNCT03519412Phase 2Results posted
• Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)TerminatedNCT03515824Phase 1Results posted
• Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal CancerCompletedNCT03475004Phase 2Results posted
• Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal CancerCompletedNCT03439462Phase 1/2Results posted
• M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite InstabilityCompletedNCT03436563Phase 1/2Results posted
• Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal CancerCompletedNCT03435107Phase 2Results posted
• A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentCompletedNCT03428958Phase 1/2Results posted
• Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon CancerCompletedNCT03428126Phase 2Results posted
• Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard TreatmentCompletedNCT03427268Phase 2Results posted
• An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has SpreadCompletedNCT03414983Phase 2/3Results posted
• U01 CRC Project for Vietnamese AmericansCompletedNCT03413605Not applicableResults posted
• Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT03403634Phase 2Results posted
• Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal PolyposisCompletedNCT03401229Phase 3Results posted
• Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal CancerCompletedNCT03396926Phase 2Results posted
• PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO)CompletedNCT03391232Phase 1/2Results posted
• DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)CompletedNCT03384940Phase 2Results posted
• An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has SpreadCompletedNCT03377361Phase 1/2Results posted
• Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)CompletedNCT03374254Phase 1Results posted
• A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and BevacizumabTerminatedNCT03368859Phase 2Results posted
• Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT03366155Phase 2Results posted
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerCompletedNCT03362177Phase 3Results posted
• Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerActive, not recruitingNCT03337087Phase 1/2Results posted
• Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal CancersCompletedNCT03332498Phase 1/2Results posted
• A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsCompletedNCT03314935Phase 1/2Results posted
• Dolcanatide in Preventing Colorectal Cancer in Healthy VolunteersCompletedNCT03300570Phase 1Results posted
• Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation RegimensCompletedNCT03298945Phase 4Results posted
• Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal CancerCompletedNCT03288987Phase 3Results posted
• Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRCCompletedNCT03274804Phase 1Results posted
• Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer TrialCompletedNCT03265483Not applicableResults posted
• Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal CancerCompletedNCT03263429Phase 1/2Results posted
• A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsCompletedNCT03261947Phase 2Results posted
• Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesCompletedNCT03256344Phase 1Results posted
• Lidocaine for Oxaliplatin-induced NeuropathyCompletedNCT03254394Phase 1/2Results posted
• Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid TumorCompletedNCT03239145Phase 1Results posted

← Colorectal Neoplasms overview